Conjunctivitis Among Individuals with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab in the United States

被引：0

作者：

Franklin, Jessica M. ^{[1
]}

Marcus, Andrea F. ^{[2
]}

Sultan, Ihtisham ^{[3
]}

Howell, Ashley ^{[3
]}

Sinnott, Sarah-Jo ^{[4
]}

Green, Jeannette ^{[3
]}

Ezzy, Stephen M. ^{[1
]}

Gately, Robert ^{[1
]}

Sobel, Rachel E. E. ^{[3
]}

Wang, Florence ^{[1
]}

机构：

[1] Optum, Eden Prairie, MN USA

[2] Regeneron Pharmaceut, Tarrytown, NY USA

[3] Regeneron, Tarrytown, NY USA

[4] Sanofi, Paris, France

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

221

引用

页码：77 / 78

页数：2

共 50 条

[21] A study into the drug dupilumab in Japanese adults with moderate-to-severe atopic dermatitis
不详
BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (01) : E4 - E4
[22] Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
Kuznik, Andreas
Bego-Le-Bagousse, Gaelle
Eckert, Laurent
Gadkari, Abhijit
Simpson, Eric
Graham, Christopher N.
Miles, LaStella
Mastey, Vera
Mahajan, Puneet
Sullivan, Sean D.
DERMATOLOGY AND THERAPY, 2017, 7 (04) : 493 - 505
[23] Dupilumab Treatment Reduces Hospitalizations in Adults With Moderate-to-Severe Atopic Dermatitis
Silverberg, Jonathan, I
Rubini, Norma P. M.
Pires, Mario C.
Rossi, Ana B.
Zhang, Annie
Chen, Zhen
Levit, Noah A.
Chao, Jingdong
Shumel, Brad
Bego-Le Bagousse, Gaelle
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (05): : 1279 - +
[24] Emerging Role of Atopic Dermatitis Control Tool in Long-Term Monitoring of Patients With Moderate-to-Severe Atopic Dermatitis Treated With Dupilumab
Cioppa, Vittoria
Lazzeri, Laura
Carraro, Andrea
De Piano, Ernesto
Falcinelli, Francesca
Galluzzo, Marco
Pallotta, Sabatino
De Pita, Ornella
Russo, Filomena
DERMATITIS, 2024, 35
[25] Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience
Stingeni, L.
Bianchi, L.
Antonelli, E.
Caroppo, E. S.
Ferrucci, S. M.
Ortoncelli, M.
Fabbrocini, G.
Nettis, E.
Schena, D.
Napolitano, M.
Gola, M.
Bonzano, L.
Rossi, M.
Fortina, A. Belloni
Balato, A.
Peris, K.
Foti, C.
Guarneri, F.
Romanelli, M.
Patruno, C.
Savoia, P.
Fargnoli, M. C.
Russo, F.
Errichetti, E.
Bianchelli, T.
Bianchi, L.
Pellacani, G.
Feliciani, C.
Offidani, A.
Corazza, M.
Micali, G.
Milanesi, N.
Malara, G.
Chiricozzi, A.
Tramontana, M.
Hansel, K.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (08) : 1292 - 1299
[26] Long-term follow-up in patients with moderate-to-severe atopic dermatitis treated with dupilumab
Votto, M.
Fortina, V.
De Filippo, M.
Naso, M.
Villanova, M.
Licari, A.
Marseglia, G. L.
Brazzelli, V.
ALLERGY, 2023, 78
[27] Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
Mareschal, Adrien
Puzenat, Eve
Aubin, Francois
ACTA DERMATO-VENEREOLOGICA, 2020, 100 (01)
[28] Drug survival of dupilumab compared to cyclosporin in moderate-to-severe atopic dermatitis patients
Dal Bello, Giacomo
Maurelli, Martina
Schena, Donatella
Girolomoni, Giampiero
Gisondi, Paolo
DERMATOLOGIC THERAPY, 2020, 33 (06)
[29] DUPILUMAB TREATMENT RAPIDLY IMPROVES ITCH IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
Silverberg, J.
Chao, J.
Eckert, L.
Chen, Z.
Ardeleanu, M.
Shumel, B.
Plaum, S.
Graham, N.
Pirozzi, G.
Gadkari, A.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S95 - S95
[30] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
Kim, Nicole S.
Maliyar, Khalad
Oliveira, Luciana
O'Toole, Ashley
Gooderham, Melinda J.
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363

← 1 2 3 4 5 →